Hallel Rosenberg-Fogler

Hallel Rosenberg-Fogler

Auto-generated profile, based on publicly available information

Hallel Rosenberg-Fogler

Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in Cancer Discovery
Verified
Journal Article
Closed access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas. Significance: Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies. See related commentary by Sherman, p. 1096

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Table 5: Antibody list

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Video 5 shows Cytopainter red-labeled pCAFs were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1 cells and immediately imaged for 16 hours

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA